Skip to main content
Top
Published in: BMC Cancer 1/2024

Open Access 01-12-2024 | Glioma | Retraction Note

Retraction Note: Swainsonine represses glioma cell proliferation, migration and invasion by reduction of miR-92a expression

Authors: Libo Sun, Xingyi Jin, Lijuan Xie, Guangjun Xu, Yunxia Cui, Zhuo Chen

Published in: BMC Cancer | Issue 1/2024

Login to get access

Excerpt

Retraction Note: BMC Cancer 19, 247 (2019)
Metadata
Title
Retraction Note: Swainsonine represses glioma cell proliferation, migration and invasion by reduction of miR-92a expression
Authors
Libo Sun
Xingyi Jin
Lijuan Xie
Guangjun Xu
Yunxia Cui
Zhuo Chen
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-024-12034-x

Other articles of this Issue 1/2024

BMC Cancer 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine